Institutional members access full text with Ovid®

Share this article on:

Is Psychiatry Ignoring Suicide?: The Case for Clozapine

Sinyor, Mark MSc, MD*; Remington, Gary MD, PhD, FRCPC†‡

Journal of Clinical Psychopharmacology: June 2012 - Volume 32 - Issue 3 - p 307–308
doi: 10.1097/JCP.0b013e31825501fb
Guest Editorial

From the *Department of Psychiatry, Sunnybrook Health Sciences Centre, and †Schizophrenia Head, Brain and Behaviour Program, Department of Psychiatry, University of Toronto; and ‡Medication Clinic, Schizophrenia Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Reprints: Mark Sinyor, MSc, MD, Department of Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave, Toronto, Ontario, Canada M4N 3M5 (e-mail: mark.sinyor@utoronto.ca).

© 2012 Lippincott Williams & Wilkins, Inc.